NELL2 Modulates Cell Proliferation and Apoptosis via ERK Pathway in the Development of Benign Prostatic Hyperplasia.
暂无分享,去创建一个
Xinghuan Wang | Ping Chen | Xinhua Zhang | Xun Fu | Jianmin Liu | Daoquan Liu | Weixiang He | Yan Li | Mingzhou Li | M. DiSanto | Xueneng Zhang | Guang Zeng
[1] Shuntai Chen,et al. IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas , 2020, Signal Transduction and Targeted Therapy.
[2] R. Dhir,et al. Tight junction protein claudin‐1 is downregulated by TGF‐β1 via MEK signaling in benign prostatic epithelial cells , 2020, The Prostate.
[3] Eun Jin Seo,et al. NELL2 Function in Axon Development of Hippocampal Neurons , 2020, Molecules and cells.
[4] M. Matzuk,et al. NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility , 2020, Science.
[5] Xinghuan Wang,et al. Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate , 2020, Aging.
[6] Prakash Kulkarni,et al. Stromal‐epithelial interactions in prostate cancer: Overexpression of PAGE4 in stromal cells inhibits the invasive ability of epithelial cells , 2020, Journal of cellular biochemistry.
[7] X. Tan,et al. Dysregulated Tgfbr2/ERK-Smad4/SOX2 signaling promotes lung squamous cell carcinoma formation. , 2019, Cancer research.
[8] Chao Li,et al. Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway , 2019, BMC Complementary and Alternative Medicine.
[9] R. Seger,et al. Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer , 2019, International journal of molecular sciences.
[10] Xinghuan Wang,et al. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia , 2019, Front. Endocrinol..
[11] Jialu Zhang,et al. Stomatin‐like protein 2 inhibits cisplatin‐induced apoptosis through MEK/ERK signaling and the mitochondrial apoptosis pathway in cervical cancer cells , 2018, Cancer science.
[12] Zhiguang Qiao,et al. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway. , 2017, Clinical science.
[13] B. Lee,et al. A Role of Central NELL2 in the Regulation of Feeding Behavior in Rats , 2017, Molecules and cells.
[14] Zhongjun Liu,et al. Regulation of Intrinsic and Extrinsic Apoptotic Pathways in Osteosarcoma Cells Following Oleandrin Treatment , 2016, International journal of molecular sciences.
[15] W. Xue,et al. Regulation of Prostate Development and Benign Prostatic Hyperplasia by Autocrine Cholinergic Signaling via Maintaining the Epithelial Progenitor Cells in Proliferating Status , 2016, Stem cell reports.
[16] G. Morgia,et al. Endocrine control of benign prostatic hyperplasia , 2016, Andrology.
[17] G. Andriole,et al. Management of Benign Prostatic Hyperplasia. , 2016, Annual review of medicine.
[18] M. Oelke,et al. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. , 2015, European urology.
[19] P. Xie,et al. iTRAQ-based quantitative proteomic analysis of cerebrospinal fluid reveals NELL2 as a potential diagnostic biomarker of tuberculous meningitis. , 2015, International journal of molecular medicine.
[20] R. Kirby,et al. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) – focus on the UK , 2015, BJU international.
[21] Ritsuko Nakamura,et al. Expression and regulatory effects on cancer cell behavior of NELL1 and NELL2 in human renal cell carcinoma , 2015, Cancer science.
[22] E. Choi,et al. Compromised MAPK signaling in human diseases: an update , 2015, Archives of Toxicology.
[23] K. Eliceiri,et al. Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules , 2014, PloS one.
[24] E. J. Choi,et al. Neural Epidermal Growth Factor-Like Like Protein 2 (NELL2) Promotes Aggregation of Embryonic Carcinoma P19 Cells by Inducing N-Cadherin Expression , 2014, PloS one.
[25] J. Macoska,et al. Prostatic fibrosis, lower urinary tract symptoms, and BPH , 2013, Nature Reviews Urology.
[26] Dong Hee Kim,et al. The E2F1 oncogene transcriptionally regulates NELL2 in cancer cells. , 2013, DNA and cell biology.
[27] A. Salonia,et al. Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. , 2013, Urology.
[28] J. Hollingsworth,et al. Prostatic fibrosis is associated with lower urinary tract symptoms. , 2012, The Journal of urology.
[29] J. Caprioli,et al. The Neuronal EGF-Related Gene Nell2 Interacts with Macf1 and Supports Survival of Retinal Ganglion Cells after Optic Nerve Injury , 2012, PloS one.
[30] B. Lee,et al. Regulation of the female rat estrous cycle by a neural cell-specific epidermal growth factor-like repeat domain containing protein, NELL2 , 2011, Molecules and cells.
[31] E. J. Choi,et al. Estrogen-dependent Transcription of the NEL-like 2 (NELL2) Gene and Its Role in Protection from Cell Death* , 2010, The Journal of Biological Chemistry.
[32] J. Chambard,et al. ERK and cell death: Mechanisms of ERK‐induced cell death – apoptosis, autophagy and senescence , 2010, The FEBS journal.
[33] B. Lee,et al. Region- and neuronal phenotype-specific expression of NELL2 in the adult rat brain. , 2008, Molecules and cells.
[34] J. Pouysségur,et al. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.
[35] M. Berger,et al. Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. , 2006, Neuro-oncology.
[36] John T. Wei,et al. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the united states , 2006, Current urology reports.
[37] Hong Zhong,et al. Novel Blood Biomarkers of Human Urinary Bladder Cancer , 2006, Clinical Cancer Research.
[38] S. Nair,et al. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. , 2006, Carcinogenesis.
[39] Li‐jun Wu,et al. Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression in shikonin-induced HeLa cell apoptosis. , 2005, Chinese medical journal.
[40] R. Craig,et al. MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol , 2004, Oncogene.
[41] B. Nelson,et al. NELL2 promotes motor and sensory neuron differentiation and stimulates mitogenesis in DRG in vivo. , 2004, Developmental biology.
[42] Jun Luo,et al. Decreased gene expression of steroid 5 alpha‐reductase 2 in human prostate cancer: Implications for finasteride therapy of prostate carcinoma , 2003, The Prostate.
[43] K. Tanizawa,et al. A neuron-specific EGF family protein, NELL2, promotes survival of neurons through mitogen-activated protein kinases. , 2003, Brain research. Molecular brain research.
[44] L. Greene,et al. Nerve Growth Factor (NGF) Down-regulates the Bcl-2 Homology 3 (BH3) Domain-only Protein Bim and Suppresses Its Proapoptotic Activity by Phosphorylation* , 2002, The Journal of Biological Chemistry.
[45] C. Ha,et al. Ontogeny and the possible function of a novel epidermal growth factor‐like repeat domain‐containing protein, NELL2, in the rat brain , 2002, Journal of neurochemistry.
[46] F. Porteu,et al. IEX‐1: a new ERK substrate involved in both ERK survival activity and ERK activation , 2002, The EMBO journal.
[47] H. Schägger. Respiratory chain supercomplexes of mitochondria and bacteria. , 2002, Biochimica et biophysica acta.
[48] M Hareyama,et al. MEK/ERK pathway protects ionizing radiation-induced loss of mitochondrial membrane potential and cell death in lymphocytic leukemia cells , 2002, Cell Death and Differentiation.
[49] A. Borkhardt,et al. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines , 2002, Cancer Chemotherapy and Pharmacology.
[50] J. Trent,et al. Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis , 2002, The Prostate.
[51] T. Mak,et al. ERK Activation Mediates Cell Cycle Arrest and Apoptosis after DNA Damage Independently of p53* , 2002, The Journal of Biological Chemistry.
[52] Huitu Liu,et al. MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.
[53] I. Pastan,et al. PAGE4 is a cytoplasmic protein that is expressed in normal prostate and in prostate cancers. , 2002, Molecular cancer therapeutics.
[54] Hung-Yun Lin,et al. Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK- and p53-dependent mechanism. , 2002, The Journal of clinical endocrinology and metabolism.
[55] S. Kuroda,et al. Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors. , 2001, Neurologia medico-chirurgica.
[56] P. Fisher,et al. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. , 2001, Molecular biology of the cell.
[57] A. Papatsoris,et al. Molecular 'palpation' of BPH: a tale of MAPK signalling? , 2001, Trends in molecular medicine.
[58] S. E. F. Tran,et al. MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors* , 2001, The Journal of Biological Chemistry.
[59] A. Dilella,et al. Identification of Genes Differentially Expressed in Benign Prostatic Hyperplasia , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[60] R. Lefkowitz,et al. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades , 2001, Oncogene.
[61] M. Fujimiya,et al. Immunocytochemical localization of a neuron-specific thrombospondin-1-like protein, NELL2: light and electron microscopic studies in the rat brain. , 2000, Brain research. Molecular brain research.
[62] T. Abe,et al. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. , 1999, Biochemical and biophysical research communications.
[63] Helmut Klocker,et al. Rapid signalling by androgen receptor in prostate cancer cells , 1999, Oncogene.
[64] G. Kramer,et al. Elastin gene expression in benign prostatic hyperplasia , 1999, The Prostate.
[65] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[66] Y. Ip,et al. Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. , 1998, Current opinion in cell biology.
[67] T. Katagiri,et al. Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. , 1996, Genomics.
[68] Xiaodong Wang,et al. Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.
[69] P. Handford,et al. The structure of a Ca2+-binding epidermal growth factor-like domain: Its role in protein-protein interactions , 1995, Cell.
[70] K. Hori,et al. New gene, nel, encoding a Mr 93 K protein with EGF‐like repeats is strongly expressed in neural tissues of early stage chick embryos , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.
[71] P. Walsh,et al. The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.
[72] D. Kardamakis,et al. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis. , 2007, In vivo.
[73] R. Getzenberg,et al. Fingerprinting the diseased prostate: Associations between BPH and prostate cancer , 2004, Journal of cellular biochemistry.
[74] Li Sheng-mei,et al. On the Structure of "秀才秀才,错字布袋 , 2003 .
[75] R. Davis,et al. Signal transduction by the c-Jun N-terminal kinase. , 1999, Biochemical Society symposium.
[76] G. Kramer,et al. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. , 1992, Laboratory investigation; a journal of technical methods and pathology.